Dermatology, Pediatric Dermatology · Scottsdale, AZ
NPI
1679928832
Since 2016
Specialty
Dermatology, Pediatric Dermatology
Code 207NP0225X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
20401 N 73rd St Ste 230
Scottsdale, AZ, 85255
Phone (480) 556-0446
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
695 services
Medicare patients, 2024
171
Average age 73
Drug cost, 2024
$377K
783 prescriptions
Company payments, 2025
$256K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karan Lal was code 99214 (office e&m - established), 158 times for 83 patients. In total Karan Lal billed 695 services in 51 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 158 | 83 | $85.91 | $14K |
| 17003 Destruction Skin Lesion | Office | 120 | 19 | $5.00 | $600 |
| 99213 Office E&M - Established | Office | 79 | 56 | $60.60 | $4,787 |
| 11102 Skin Biopsy | Office | 41 | 35 | $58.53 | $2,400 |
| 17110 Destruction Skin Lesion | Office | 37 | 29 | $68.00 | $2,516 |
| 17000 Destruction Skin Lesion | Office | 32 | 27 | $35.90 | $1,149 |
| 99212 Office E&M - Established | Office | 28 | 25 | $34.42 | $964 |
| 99204 Office E&M - New | Office | 24 | 24 | $92.94 | $2,231 |
| 99203 Office E&M - New | Office | 12 | 12 | $43.08 | $517 |
By year: 2022 $42K for 979 services; 2023 $24K for 377 services; 2024 $44K for 695 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karan Lal prescribed most often to Medicare patients was Minoxidil, with 102 prescriptions and refills. In total Karan Lal wrote 783 Medicare prescriptions that cost $377K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Minoxidil Generic | 102 | 174 | 19 | $966 |
| Ketoconazole Generic | 58 | 63 | 23 | $962 |
| Cephalexin Generic | 31 | 31 | 25 | $289 |
| Clobetasol Propionate Generic | 30 | 30 | 15 | $1,978 |
| Mometasone Furoate Generic | 29 | 29 | 17 | $563 |
| Doxycycline Monohydrate Generic | 28 | 29 | 17 | $572 |
| Valacyclovir Valacyclovir Hcl | 28 | 28 | 26 | $284 |
| Opzelura Ruxolitinib Phosphate | 24 | 40 | Under 11 | $67K |
| Methotrexate Methotrexate Sodium | 23 | 23 | Under 11 | $116 |
| Dupixent Pen Dupilumab | 23 | 23 | Under 11 | $84K |
| Fluconazole Generic | 20 | 20 | 18 | $205 |
| Ammonium Lactate Generic | 18 | 31 | Under 11 | $299 |
| Fluorouracil Generic | 15 | 16 | 13 | $975 |
| Hydrocortisone Generic | 12 | 14 | 11 | $287 |
| Triamcinolone Acetonide Generic | 12 | 13 | Under 11 | $269 |
Brand drugs: 130 claims; generic drugs: 653 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karan Lal $256K ($256K in general payments such as food, travel and fees) from 27 companies. The largest payer was Galderma Laboratories, L.P. with $37K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 49 | $37K |
| Incyte Corporation INCY | 48 | $36K |
| Lilly USA, LLC LLY | 21 | $26K |
| Abbvie Inc. ABBV | 45 | $23K |
| Genzyme Corporation SNY | 19 | $21K |
| Arcutis Biotherapeutics, Inc. ARQT | 44 | $19K |
| Pfizer Inc. PFE | 28 | $19K |
| Eli Lilly and Company LLY | 6 | $17K |
| Regeneron Healthcare Solutions, Inc. REGN | 15 | $15K |
| Organon LLC OGN | 37 | $12K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.